Works matching IS 15391604 AND DT 2020 AND VI 19 AND IP 3

Results: 18

Comment on: Ripamonti E, Lloyd CJ. Tests for noninferiority trials with binomial endpoints: A guide to modern and quasi‐exact methods for biomedical researchers. Pharm Stat 2019;18:377‐387. https://onlinelibrary.wiley.com/doi/10.1002/pst.1929.

Published in:

Pharmaceutical Statistics, 2020, v. 19, n. 3, p. 350, doi. 10.1002/pst.1998

By:

Almendra‐Arao, Félix;
Sotres‐Ramos, David

Publication type:

Article

Comparisons of outlier tests for potency bioassays.

Published in:

Pharmaceutical Statistics, 2020, v. 19, n. 3, p. 230, doi. 10.1002/pst.1984

By:

Sondag, Perceval;
Zeng, Lingmin;
Yu, Binbing;
Yang, Harry;
Novick, Steven

Publication type:

Article

Two‐stage phase II survival trial design.

Published in:

Pharmaceutical Statistics, 2020, v. 19, n. 3, p. 214, doi. 10.1002/pst.1983

By:

Wu, Jianrong;
Chen, Li;
Wei, Jing;
Weiss, Heidi;
Chauhan, Aman

Publication type:

Article

Cancer immunotherapy trial design with delayed treatment effect.

Published in:

Pharmaceutical Statistics, 2020, v. 19, n. 3, p. 202, doi. 10.1002/pst.1982

By:

Wu, Jianrong;
Wei, Jing

Publication type:

Article

Reply to Drs Almendra‐Arao and Sotres‐Ramos regarding Barnard's concept of convexity and possible extensions.

Published in:

Pharmaceutical Statistics, 2020, v. 19, n. 3, p. 353, doi. 10.1002/pst.1997

By:

Ripamonti, Enrico;
Lloyd, Chris

Publication type:

Article

TITE‐BOIN‐ET: Time‐to‐event Bayesian optimal interval design to accelerate dose‐finding based on both efficacy and toxicity outcomes.

Published in:

Pharmaceutical Statistics, 2020, v. 19, n. 3, p. 335, doi. 10.1002/pst.1995

By:

Takeda, Kentaro;
Morita, Satoshi;
Taguri, Masataka

Publication type:

Article

Empowering phase II clinical trials to reduce phase III failures.

Published in:

Pharmaceutical Statistics, 2020, v. 19, n. 3, p. 178, doi. 10.1002/pst.1980

By:

De Martini, Daniele

Publication type:

Article

Discussion on statistical analysis of carcinogenicity studies with an early terminated treated group.

Published in:

Pharmaceutical Statistics, 2020, v. 19, n. 3, p. 326, doi. 10.1002/pst.1994

By:

Saul, Jim;
Ashcroft‐Hawley, Kelly

Publication type:

Article

A flexible multi‐domain test with adaptive weights and its application to clinical trials.

Published in:

Pharmaceutical Statistics, 2020, v. 19, n. 3, p. 315, doi. 10.1002/pst.1993

By:

Zhao, Yang;
Yu, Qifeng;
Lake, Stephen L.

Publication type:

Article

Enrichment designs using placebo nonresponders.

Published in:

Pharmaceutical Statistics, 2020, v. 19, n. 3, p. 303, doi. 10.1002/pst.1992

By:

Benda, Norbert;
Haenisch, Britta

Publication type:

Article

A Bayesian approach to sequential analysis in post‐licensure vaccine safety surveillance.

Published in:

Pharmaceutical Statistics, 2020, v. 19, n. 3, p. 291, doi. 10.1002/pst.1991

By:

Li, Rongxia;
Stewart, Brock;
Rose, Charles

Publication type:

Article

Leveraging historical data into oncology development programs: Two case studies of phase 2 Bayesian augmented control trial designs.

Published in:

Pharmaceutical Statistics, 2020, v. 19, n. 3, p. 276, doi. 10.1002/pst.1990

By:

Smith, Claire L.;
Thomas, Zachary;
Enas, Nathan;
Thorn, Katharine;
Lahn, Michael;
Benhadji, Karim;
Cleverly, Ann

Publication type:

Article

Multistate modeling of clinical hold in randomized clinical trials.

Published in:

Pharmaceutical Statistics, 2020, v. 19, n. 3, p. 262, doi. 10.1002/pst.1989

By:

Nießl, Alexandra;
Beyersmann, Jan;
Loos, Anja

Publication type:

Article

Covariate adjustment for randomized controlled trials revisited.

Published in:

Pharmaceutical Statistics, 2020, v. 19, n. 3, p. 255, doi. 10.1002/pst.1988

By:

Wang, Jixian

Publication type:

Article

Sequential parallel comparison design with two coprimary endpoints.

Published in:

Pharmaceutical Statistics, 2020, v. 19, n. 3, p. 243, doi. 10.1002/pst.1987

By:

Homma, Gosuke;
Daimon, Takashi

Publication type:

Article

The win ratio: Impact of censoring and follow‐up time and use with nonproportional hazards.

Published in:

Pharmaceutical Statistics, 2020, v. 19, n. 3, p. 168, doi. 10.1002/pst.1977

By:

Dong, Gaohong;
Huang, Bo;
Chang, Yu‐Wei;
Seifu, Yodit;
Song, James;
Hoaglin, David C.

Publication type:

Article

Issue Information.

Published in:: Pharmaceutical Statistics, 2020, v. 19, n. 3, p. 165, doi. 10.1002/pst.1959
Publication type:: Article

Nonlinear mixed‐effects models with misspecified random‐effects distribution.

Published in:

Pharmaceutical Statistics, 2020, v. 19, n. 3, p. 187, doi. 10.1002/pst.1981

By:

Drikvandi, Reza

Publication type:

Article